Jacobs Levy Equity Management
TVTX icon

Jacobs Levy Equity Management’s Travere Therapeutics TVTX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$10.9M Sell
735,251
-127,837
-15% -$1.89M 0.04% 289
2025
Q1
$15.5M Sell
863,088
-1,311,125
-60% -$23.5M 0.06% 267
2024
Q4
$37.9M Buy
2,174,213
+583,836
+37% +$10.2M 0.13% 155
2024
Q3
$22.2M Sell
1,590,377
-299,467
-16% -$4.19M 0.09% 218
2024
Q2
$15.5M Buy
1,889,844
+765,159
+68% +$6.29M 0.06% 269
2024
Q1
$8.67M Sell
1,124,685
-593,513
-35% -$4.58M 0.04% 322
2023
Q4
$15.4M Buy
1,718,198
+46,428
+3% +$417K 0.08% 248
2023
Q3
$14.9M Buy
1,671,770
+146,970
+10% +$1.31M 0.09% 211
2023
Q2
$23.4M Buy
1,524,800
+59,048
+4% +$907K 0.14% 176
2023
Q1
$33M Buy
1,465,752
+581,490
+66% +$13.1M 0.2% 128
2022
Q4
$18.6M Buy
884,262
+156,148
+21% +$3.28M 0.13% 201
2022
Q3
$17.9M Buy
728,114
+170,211
+31% +$4.19M 0.14% 184
2022
Q2
$13.5M Sell
557,903
-367,541
-40% -$8.91M 0.1% 228
2022
Q1
$23.8M Sell
925,444
-13,648
-1% -$352K 0.16% 158
2021
Q4
$29.1M Sell
939,092
-93,306
-9% -$2.9M 0.2% 128
2021
Q3
$25M Buy
1,032,398
+241,467
+31% +$5.86M 0.17% 155
2021
Q2
$11.5M Buy
790,931
+149,759
+23% +$2.19M 0.08% 265
2021
Q1
$16M Sell
641,172
-4,878
-0.8% -$122K 0.12% 208
2020
Q4
$17.6M Sell
646,050
-23,325
-3% -$636K 0.15% 162
2020
Q3
$12.4M Sell
669,375
-14,871
-2% -$275K 0.13% 177
2020
Q2
$14M Buy
684,246
+84,355
+14% +$1.72M 0.15% 162
2020
Q1
$8.75M Sell
599,891
-24,676
-4% -$360K 0.11% 200
2019
Q4
$8.87M Buy
624,567
+215,474
+53% +$3.06M 0.09% 267
2019
Q3
$4.74M Buy
409,093
+211,058
+107% +$2.45M 0.06% 346
2019
Q2
$3.98M Buy
198,035
+45,100
+29% +$906K 0.06% 389
2019
Q1
$3.46M Buy
152,935
+124,319
+434% +$2.81M 0.05% 398
2018
Q4
$648K Sell
28,616
-490
-2% -$11.1K 0.01% 692
2018
Q3
$836K Buy
29,106
+1,376
+5% +$39.5K 0.01% 679
2018
Q2
$756K Sell
27,730
-1,470
-5% -$40.1K 0.01% 722
2018
Q1
$653K Buy
29,200
+6,800
+30% +$152K 0.01% 728
2017
Q4
$472K Buy
+22,400
New +$472K 0.01% 766